Esco Aster Logo
  • Library
  • Careers
  • News
  • Contact Us
  • About Us
    • Our Mission and Vision
    • What We Do
    • Our Track Record
    • Our Location
    • Our Certificates
    • Our History
    • Our Senior Management
  • Our Offering
      Product and Company Life Cycle
      Early Development
        Consultancy & Fractional Talent
      Starting Material/Cell line
        Strain Engineering / Development Services Cell Line Creation Master Cell / Microbial Banking
      Process & CMC Development
        cGMP Process Development Exosome Nasal Formulation Development
      cGMP Manufacturing
        Process Transfer Clinical Trial Material Drug Product: Aseptic Fill & Finish
      Business & Strategic Support
        Esco Aster Strategic Capital (Fundraising) As A Service With Accredited Investors
      By Modality
      Animal Health
        Canine CAR-T Cell Therapy Monoclonal Antibodies for Companion Animals Animal Health Services
      Plasmid DNA Manufacturing Services Extracellular Vesicles Cell Therapy Gene Therapy Human Vaccines Viral Vector Production Services Lipid Nanoparticle Development and Formulation Services Genetically-modified Cell Therapy Precision Fermentation
  • Research Services
  • Enterprise Solutions
  • Manufacturing Platforms
      Adherent Tide Motion® Technology Astericle™: The New EV Miracle Continuous Fermentation Continuous Flow Chemistry/ Small Molecules Esco AsterMavors®
  • Our Products
      COVID-19 API Process Development Cosmetics and Cosmeceuticals Functional Peptides Specialty Diagnostics
  • How We Work
  • Library
  • Careers
  • News
  • Contact Us
One World Biosolutions for One Health
Searching
  1. Track Record
  2. Animal Health

Controlling Global Health Risks Through ‘One Health’ Vaccination Approach

We are driven to provide One Health-based measures, geared towards vaccination and less antibiotic dependence, to ensure animals considered as companions and nourishment providers, are free from diseases that transcends human and environmental health systems.

  • Hog Cholera Vaccine
  • Infectious Bursal Disease Virus (IBDV) Vaccine
  • Porcine Reproductive and Respiratory Syndrome Vaccine (PRRSV)
  • Rabies Vaccine

asdasdad

We are driven to provide One Health-based measures, geared towards vaccination and less antibiotic dependence, to ensure animals considered as companions and nourishment providers, are free from diseases that transcends human and environmental health systems.

  • Hog Cholera Vaccine
  • Infectious Bursal Disease Virus (IBDV) Vaccine
  • Porcine Reproductive and Respiratory Syndrome Vaccine (PRRSV)
  • Rabies Vaccine

Esco Aster Pte Ltd is a cGMP CRDMO operating as an independent subsidiary of Esco Lifesciences Group. We provide process development (PD) and contract manufacturing (from upstream to downstream, formulation and filling), consultation, and clinical research services bridging the translation gap from bench to bedside.


#02-01, Blk 67 Ayer Rajah Crescent, Singapore 139950,
+65 6251 9361
[email protected]

#02-04 Blk 67 Ayer Rajah Crescent Singapore 139950
+65 6251 9361
[email protected]

#03-20 Blk 71 Ayer Rajah Crescent Singapore 139951
+65 6251 9361
[email protected]
Products
  • COVID-19
  • API Process Development
  • Cosmetics and Cosmeceuticals
  • Functional Peptides
  • Specialty Diagnostics
Solutions
  • One Health Vaccines
  • Cell & Gene Therapy
Customer Service
Terms and Conditions
Purchase Order Terms and Conditions
Privacy Policy
Conditions Of Supply
Quality Policy
Our Offerings
  • Cellular Agriculture/Complementary Proteins
  • Plasmid DNA Manufacturing Services
  • Extracellular Vesicles
  • Cell Therapy
  • Gene Therapy
  • Human Vaccines
  • Viral Vector Production Services
  • Lipid Nanoparticle Development and Formulation Services
  • Genetically-modified Cell Therapy
  • Canine CAR-T Cell Therapy
  • Monoclonal Antibodies for Companion Animals
  • Precision Fermentation
  • Animal Health Services
  • Consultancy & Fractional Talent
  • Strain Engineering / Development Services
  • Cell Line Creation
  • Master Cell / Microbial Banking
  • cGMP Process Development
  • Exosome Nasal Formulation Development
  • Process Transfer
  • Clinical Trial Material
  • Drug Product: Aseptic Fill & Finish
  • Esco Aster Strategic Capital (Fundraising) As A Service With Accredited Investors
© 2026 Esco Aster Pte. Ltd. All rights reserved. | Best viewed in Google Chrome.